HomeNDC LookupRxCUI directory › RxCUI 199106

Pyrantel pamoate 144 MG/ML Oral Suspension — RxCUI 199106

RxNorm drug concept · Semantic clinical drug
RxCUI 199106 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 11 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI199106
Official namePyrantel pamoate 144 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspyrantel pamoate 144 MG per 1 ML Oral Suspension; pyrantel pamoate 144 MG in 1 mL Oral Suspension; pyrantel pamoate 144 MG/ML (pyrantel base 50 MG/ML) Oral Suspension
FDA products mapped8
Package NDCs mapped11
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pyrantel: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Pyrantel treats pinworm infection — that's the only approved use across all the products on this page. Pinworms are small parasitic worms that can cause itching around the bottom,...
  • No — pyrantel is designed to work as a single one-time dose. You shouldn't repeat it on your own. If your symptoms or pinworms are still present after treatment, that's the signal...
  • Usually yes. Pinworms spread very easily from person to person, so all household members are typically treated at the same time to prevent re-infection. Your product's label recomm...
  • Does the whole family need to be treated?
📖 Read our full Pyrantel guide →

🕸️ Concept Web — How Pyrantel pamoate 144 MG/ML Oral Suspension Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Pyrantel pamoate 144 MG/ML Oral Suspension RxCUI 199106

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Pyrantel 8984
    • Pyrantel pamoate 8985
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Ascarel 215422
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pyrantel Oral Suspension 373699
    • Pyrantel pamoate Oral Suspension 2645511
    • Pyrantel Oral Liquid Product 1163595
    • Pyrantel Oral Product 1163596
    • Pyrantel pamoate Oral Liquid Product 2659138
    • Pyrantel pamoate Oral Product 2660764
    • Pyrantel Oral Suspension [Ascarel] 366093
    • Pyrantel pamoate Oral Suspension [Ascarel] 2656872
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Pyrantel pamoate 144 MG/ML 1661534
    • Pyrantel pamoate 144 MG/ML Oral Suspension [Ascarel] 404175
    • Pyrantel pamoate 144 MG/ML [Ascarel] 1661538

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Pyrantel pamoate 144 MG/ML SCDC · 1661534
  • Pyrantel Oral Suspension SCDF · 373699
  • Pyrantel pamoate Oral Suspension SCDFP · 2645511
  • Pyrantel Oral Liquid Product SCDG · 1163595
  • Pyrantel Oral Product SCDG · 1163596
  • Pyrantel pamoate Oral Liquid Product SCDGP · 2659138
  • Pyrantel pamoate Oral Product SCDGP · 2660764

Brand-Name Concepts

  • Pyrantel pamoate 144 MG/ML Oral Suspension [Ascarel] SBD · 404175
  • Pyrantel pamoate 144 MG/ML [Ascarel] SBDC · 1661538
  • Pyrantel Oral Suspension [Ascarel] SBDF · 366093
  • Pyrantel pamoate Oral Suspension [Ascarel] SBDFP · 2656872
  • Ascarel Oral Liquid Product SBDG · 1171453
  • Ascarel Oral Product SBDG · 1171454
  • Ascarel BN · 215422

📦 FDA Products & Package NDCs

8 products · 11 package NDCs
11 package NDCs map to RxCUI 199106 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00363-0618-01 1 BOTTLE, PLASTIC in 1 CARTON (0363-0618-01) / 30 mL in 1 B... Walgreens Pinworm Medicine Walgreens 2015-11-16
10956-0778-01 1 BOTTLE, PLASTIC in 1 CARTON (10956-778-01) / 30 mL in 1 B... Pinworm Medicine REESE PHARMACEUTICAL CO. 2022-09-28
10956-0778-02 2 BOTTLE, PLASTIC in 1 CARTON (10956-778-02) / 30 mL in 1 B... Pinworm Medicine REESE PHARMACEUTICAL CO. 2022-09-28
46122-0825-29 1 BOTTLE in 1 CARTON (46122-825-29) / 30 mL in 1 BOTTLE pinworm treatment AMERISOURCE BERGEN 2026-01-21
53145-0101-11 1 BOTTLE in 1 BOX (53145-101-11) / 30 mL in 1 BOTTLE (53145... PARASITOL Menper Distributors Inc. 2013-01-01
58988-1770-01 1 BOTTLE in 1 CARTON (58988-1770-1) / 30 mL in 1 BOTTLE Pyrantel Pamoate ProMex LLC 2002-09-27
69452-0515-38 2 BOTTLE in 1 CARTON (69452-515-38) / 30 mL in 1 BOTTLE (69... pinworm treatment BIONPHARMA INC. 2025-09-08
69452-0515-49 1 BOTTLE in 1 CARTON (69452-515-49) / 30 mL in 1 BOTTLE pinworm treatment BIONPHARMA INC. 2026-01-23
69452-0515-88 473 mL in 1 BOTTLE (69452-515-88) pinworm treatment BIONPHARMA INC. 2025-09-08
69842-0618-02 2 BOTTLE, PLASTIC in 1 CARTON (69842-618-02) / 30 mL in 1 B... CVS Pinworm Treatment CVS PHARMACY INC 2016-12-15
70677-1312-01 1 BOTTLE in 1 CARTON (70677-1312-1) / 30 mL in 1 BOTTLE pinworm treatment STRATEGIC SOURCING SERVICES 2025-12-05
Observed labelers: BIONPHARMA INC. (3) · REESE PHARMACEUTICAL CO. (2) · AMERISOURCE BERGEN (1) · CVS PHARMACY INC (1) · Menper Distributors Inc. (1) · ProMex LLC (1) · +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.